— Know what they know.
Not Investment Advice

DWTX NASDAQ

Dogwood Therapeutics, Inc.
1W: +7.3% 1M: -41.1% 3M: +5.8% YTD: -65.6% 1Y: -79.3% 3Y: -93.7% 5Y: -98.9%
$1.46
+0.03 (+2.10%)
 
Weekly Expected Move ±8.7%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 26 · $49.1M mcap · 9M float · 0.846% daily turnover · Short 34% of daily vol

Balance Sheet Trends

Total Assets
$94M +2164.1% ▲
5Y CAGR: +212.6%
Total Liabilities
$30M +8274.7% ▲
5Y CAGR: +41.7%
Shareholders Equity
$64M +1588.5% ▲
Cash & Investments
$15M +347.6% ▲
5Y CAGR: +116.9%
Total Debt
$16M +0.0% ▲
5Y CAGR: +33.8%
Net Debt
$738K +122.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$30M$14M$7M$3M$15M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$30M$14M$7M$3M$15M
Net Receivables$324$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$863$7K$4K$28K
Total Current Assets$31M$16M$8M$4M$17M
Property, Plant & Equip.$0$0$0$0$223K
Goodwill & Intangibles$0$0$0$0$78M
Long-Term Investments$0$0$0$0$18K
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$78M
Total Assets$31M$16M$8M$4M$94M
— Liabilities —
Accounts Payable$369K$354K$573K$112K$1M
Short-Term Debt$0$0$0$0$50K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$573K$533K$160K$0$688K
Total Current Liabilities$2M$1M$1M$359K$3M
Long-Term Debt$0$0$0$0$15M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$27M
Total Liabilities$2M$1M$1M$359K$30M
— Equity —
Common Stock$830$833$2K$77$133
Retained Earnings-$28M-$44M-$56M-$61M-$74M
Accumulated OCI$0$0$0$0-$4M
Total Stockholders Equity$30M$15M$7M$4M$64M
Total Liabilities & Equity$31M$16M$8M$4M$94M
— Key Metrics —
Total Debt$0$0$0$0$16M
Net Debt-$30M-$14M-$7M-$3M$738K
Total Investments$0$0$0$0$18K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms